European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Noninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans February 8, 2021 Dietary fiber influences the gut microbiome and melanoma immunotherapy response January 3, 2022 Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024
Noninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans February 8, 2021
Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024